U.S. flag

An official website of the United States government

NM_000465.4(BARD1):c.377_378delinsGA (p.Asp126Gly) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 28, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002351078.2

Allele description [Variation Report for NM_000465.4(BARD1):c.377_378delinsGA (p.Asp126Gly)]

NM_000465.4(BARD1):c.377_378delinsGA (p.Asp126Gly)

Gene:
BARD1:BRCA1 associated RING domain 1 [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_000465.4(BARD1):c.377_378delinsGA (p.Asp126Gly)
HGVS:
  • NC_000002.12:g.214781496_214781497delinsTC
  • NG_012047.3:g.33215_33216delinsGA
  • NM_000465.4:c.377_378delinsGAMANE SELECT
  • NM_001282543.2:c.320_321delinsGA
  • NM_001282545.2:c.215+15564_215+15565delinsGA
  • NM_001282548.2:c.158+27915_158+27916delinsGA
  • NM_001282549.2:c.364+10800_364+10801delinsGA
  • NP_000456.2:p.Asp126Gly
  • NP_001269472.1:p.Asp107Gly
  • LRG_297t1:c.377_378delinsGA
  • LRG_297:g.33215_33216delinsGA
  • LRG_297p1:p.Asp126Gly
  • NC_000002.11:g.215646220_215646221delinsTC
  • NM_000465.2:c.377_378delATinsGA
  • NR_104212.2:n.342_343delinsGA
  • NR_104215.2:n.285_286delinsGA
Protein change:
D107G
Molecular consequence:
  • NM_001282545.2:c.215+15564_215+15565delinsGA - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282548.2:c.158+27915_158+27916delinsGA - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282549.2:c.364+10800_364+10801delinsGA - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000465.4:c.377_378delinsGA - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282543.2:c.320_321delinsGA - missense variant - [Sequence Ontology: SO:0001583]
  • NR_104212.2:n.342_343delinsGA - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104215.2:n.285_286delinsGA - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002623222Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Sep 28, 2020)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV002623222.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The c.377_378delATinsGA variant, located in coding exon 4 of the BARD1 gene, results from an in-frame deletion of AT and insertion of GA at nucleotide positions 377 to 378. This results in the substitution of the aspartic acid residue for a glycine residue at codon 126, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024